Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study— IL PSO ( Italian landscape psoriasis)
Journal article published in 2022 by
Piergiorgio Malagoli,
Paolo Dapavo,
Giulia Pavia 
,
Fabrizio Amoruso,
Giuseppe Argenziano,
Federico Bardazzi,
Martina Burlando,
Carlo G. Carrera,
Giovanni Damiani ,
Valentina Dini,
Giampiero Girolomoni,
Claudio Guarneri,
Francesco Loconsole,
Alessandra Narcisi ,
Francesca Sampogna
and other authors.
,
Fabrizio Amoruso,
Giuseppe Argenziano,
Federico Bardazzi,
Martina Burlando,
Carlo G. Carrera,
Giovanni Damiani ,
Valentina Dini,
Giampiero Girolomoni,
Claudio Guarneri,
Francesco Loconsole,
Alessandra Narcisi ,
Francesca Sampogna
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 